PMID- 19522772 OWN - NLM STAT- MEDLINE DCOM- 20090821 LR - 20191210 IS - 1399-0039 (Electronic) IS - 0001-2815 (Linking) VI - 74 IP - 1 DP - 2009 Jul TI - High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR. PG - 73-80 LID - 10.1111/j.1399-0039.2009.01265.x [doi] AB - Killer immunoglobulin-like receptors (KIRs) expressed on natural killer cells are critical components of innate immunity. Interactions between KIRs and their human leukocyte antigen (HLA) ligands have been shown to influence autoimmune and infectious disease course in defined populations. However, the low throughput and high cost of current methods impede confirmation of the universality of these findings. To support large epidemiology surveys, we developed a high-throughput real-time polymerase chain reaction-based assay to identify carriers of KIR3DL1, KIR3DS1, KIR2DL2, and KIR2DL3 and their HLA ligands. The platform performed with 100% sensitivity and specificity in detection of carrier and non-carrier on reference samples. The application of this platform will further clarify the nature and impact of the KIR-HLA epistatic interaction on disease course in large global population-based studies. FAU - Koehler, R N AU - Koehler RN AD - Division of Retrovirology, US Military HIV Research Program/Henry M. Jackson Foundation, Rockville, MD 20850, USA. rkoehler@hivresearch.org FAU - Walsh, A M AU - Walsh AM FAU - Moqueet, N AU - Moqueet N FAU - Currier, J R AU - Currier JR FAU - Eller, M A AU - Eller MA FAU - Eller, L A AU - Eller LA FAU - Wabwire-Mangen, F AU - Wabwire-Mangen F FAU - Michael, N L AU - Michael NL FAU - Robb, M L AU - Robb ML FAU - McCutchan, F E AU - McCutchan FE FAU - Kijak, G H AU - Kijak GH LA - eng GR - Y1-A1-2642-11/PHS HHS/United States PT - Evaluation Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - England TA - Tissue Antigens JT - Tissue antigens JID - 0331072 RN - 0 (Histocompatibility Antigens Class I) RN - 0 (KIR2DL2 protein, human) RN - 0 (KIR2DL3 protein, human) RN - 0 (KIR3DL1 protein, human) RN - 0 (Ligands) RN - 0 (Receptors, KIR2DL2) RN - 0 (Receptors, KIR2DL3) RN - 0 (Receptors, KIR3DL1) RN - 0 (Receptors, KIR3DS1) SB - IM MH - Alleles MH - Genotype MH - Histocompatibility Antigens Class I/*genetics MH - Humans MH - Ligands MH - Polymerase Chain Reaction/*methods MH - Receptors, KIR2DL2/*genetics MH - Receptors, KIR2DL3/*genetics MH - Receptors, KIR3DL1/*genetics MH - Receptors, KIR3DS1/*genetics MH - Sensitivity and Specificity EDAT- 2009/06/16 09:00 MHDA- 2009/08/22 09:00 CRDT- 2009/06/16 09:00 PHST- 2009/06/16 09:00 [entrez] PHST- 2009/06/16 09:00 [pubmed] PHST- 2009/08/22 09:00 [medline] AID - TAN1265 [pii] AID - 10.1111/j.1399-0039.2009.01265.x [doi] PST - ppublish SO - Tissue Antigens. 2009 Jul;74(1):73-80. doi: 10.1111/j.1399-0039.2009.01265.x.